Recent bariatric-metabolic surgery

Česká verzia

Authors: P. Holéczy ^1,2; M. Bužga ³
Authors place of work: Katedra chirurgických oborů, LF OU v Ostravě ¹; Chirurgické oddělení, Vítkovická nemocnice a. s., Ostrava ²; Ústav fyziologie a patofyziologie, LF OU v Ostravě ³
Published in the journal: Gastroent Hepatol 2016; 70(6): 485-490
Category: Bariatrics
doi: https://doi.org/10.14735/amgh2016485

Summary

Bariatric surgery has more than a 60-year long history. From its origin until now, many types of operations have been proposed and have met with success to a greater or lesser degree. Some have been abandoned, while others, albeit in modified formats, are still relevant today. Currently, bariatric surgery is gradually and slowly growing in popularity throughout the world, including in the Czech Republic. The operation rate is significantly increasing. Many publications have documented its fundamental and long-term effect on weight reduction. Recently, there has been a shift in attention away from the importance of surgical intervention in weight reduction to the impact of surgical intervention on comorbidities, especially type 2 diabetes mellitus. At present, three types of operations are most frequently performed: sleeve gastrectomy, gastric bypass and adjustable gastric banding. Each type of operation has distinct metabolic consequences and a different effect on gastrointestinal hormone levels, according to the extent to which it changes the digestive tract. The most significant hormonal effect of surgically-induced changes in the gastrointestinal tract is an improvement in insulin resistance. A new approach that defines the type of operation according to the objective has attracted considerable interest. The authors present a comprehensive overview of the most commonly performed operations in the world, including in the Czech Republic, as well as a comparative analysis of the metabolic effects of each type of operation.

Key words:
bariatric-metabolic surgery – types of transactions – treatment of comorbidities – type 2 diabetes mellitus

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE „uniform requirements“ for biomedical papers.

Submitted:
26. 9. 2016

Accepted:
30. 10. 2016

Zdroje

1. Buchwald H, Varco RL. Metabolic surgery, New York: Grunt & Stratton 1978.

2. Buchwald H, Stoller DK, Campos CT et al.Partial ileal bypass for hypercholesterolemy. 20- to 26-year follow-up of the first 57 consecutive cases. Ann Surg 1990; 212(3): 318–329.

3. Pories WJ, Swanson MS, MacDonald KG et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222(3): 339–350.

4. Rubino F, Forgione A, Cummings et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006; 244(5): 741–749.

5. Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292(14): 1724–1737.

6. Buchwald H. The evolution of metabolic/ bariatric surgery. Obes Surg 2014; 24(8): 1126–1135. doi: 10.1007/ s11695-014-1354-3.

7. Sjöström L, Lindroos AK, Peltonen M et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351(26): 2683–2693.

8. Rubino F, Nathan DM, Eckel RH et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organisation. Diabetes Care 2016; 39(6): 861–877. doi: 10.2337/ dc16-0236.

9. Fried M, Yumuk V, Opper JM et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. Obesit Facts 2013; 6(5): 449–468 doi: 10.1159/ 000355480.

10. Gastrointestinal surgery for severe obesity. Consens Statement 1991; 9(1): 1–20.

11. Busetto L, Dixon J, De Luca M et al. Bariatric surgery in class I obesity: a position statement from the International federation for the surgery of obesity and metabolic disorders (IFSO). Obes Surg 2014; 24(4): 487–519. doi: 10.1007/ s11695-014-1214-1.

12. Reinhold RB. Critical analysis of long-term weight loss following gastric bypass. Surg Gynecol Obstet 1982; 155(3): 385–394.

13. Scinta W. Measuring success: a comparison of weight loss calculations. Bariatric Times 2012; 9(7): 18–20.

14. Angrisani L, Santonicola A, Iovino P et al. Bariatric surgery worldwide 2013. Obes Surg 2015; 25(10): 1822–1832. doi: 10.1007/ s11695-015-1657-z.

15. Bužga M, Zavadilová V, Holéczy P et al.Dietary intake and ghrelin and leptin changes after sleeve gastrectomy. WideochirInne Tech Maloinwazyjne 2014; 9(4): 554–561. doi: 10.5114/ wiitm.2014.45437.

16. Adamczyk P, Bužga M, Holéczy P et al. Bone mineral density and body composition after laparoscopic sleeve gastrectomy in men: a short-term longitudinal study. Int J Surg 2015; 23 (Pt A): 101–107. doi: 10.1016/ j.ijsu.2015.09.048.

17. Felsenreich DM, Langer FB, Kefurt R et al. Weight loss, weight regain, and conversions to Roux-en-Y gastric bypass: 10-year results of laparoscopic sleeve gastrectomy. Surg Obes Relat Dis 2016; pii: S1550-7289(16)00066-6. doi: 10.1016/ j.soard.2016.02.021.

18. Bužga M, Holéczy P, Švagera Z et al. Laparoscopic gastric plication and its effect on saccharide and lipid metabolism: a 12-month prospective study. Wideochir Inne Tech Maloinwazyjne 2015; 10(3): 398–405. doi: 10.5114/ wiitm.2015.54103.

19. Talebpour M, Motamedi SM, Talebpour Aet al. Twelve year experience of laparoscopic gastric plication in morbid obesity: development of the technique and patient outcomes. Ann Surg Innov Res 2012; 6(1): 7. doi: 10.1186/ 1750-1164-6-7.

20. Fried M, Doležalová K, Buchwald JN et al. Laparoscopic greater curvature plication (LGCP) for treatment of morbid obesity in a series of 244 patients. Obes Surg 2012; 22(8): 1298–1307. doi: 10.1007/ s11695-012-0684-2.

21. Scopinaro N. Metabolická chirurgie u pacientů s BMI ≤ 35 kg/ m2. In: Fried M et al. Bariatrická a metabolická chirurgie. Praha: Mladá fronta 2011: 221–222.

22. Sánchez-Pernaute A, Rubio MÁ, Cabrerizo L et al. Single-anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S) for obese diabetic patients. Surg Obes Relat Dis 2015; 11(5): 1092–1098. doi: 10.1016/ j.soard.2015.01.024.